View Clinical Trial (Medical Research Study)

ZOSTAVAX™ in Patients on Chronic/Maintenance Corticosteroids - NCT00546819-99204(Clinical Trial 188175)



ClinicalConnection.com has recently undergone an update and this page may no longer be up-to-date. Please Search For Clinical Trials to view the most current clinical trials listings.


Signup
City:  Spokane
State:  
WA
Zip Code: 99204
Conditions: Herpes Zoster
Purpose: The purpose of the study is to determine whether ZOSTAVAX™ is safe, generally well tolerated, and immunogenic in patients on chronic/maintenance corticosteroids.
Study summary:
Criteria: Inclusion Criteria: - Varicella-history positive, herpes zoster (HZ)-history negative patients - 60 years of age and older receiving chronic/maintenance systemic corticosteroid therapy at a daily dose of 5 to 20 mg of prednisone or equivalent during the 2 weeks immediately prior to enrollment and expected to continue to receive a daily dose of 5 to 20 mg of prednisone or equivalent for the 6-week primary safety follow-up period (dose may vary within this range during the 6-week post vaccination period) Exclusion Criteria: - Patients with a history of hypersensitivity reaction to gelatin or neomycin - Prior receipt of varicella or zoster vaccine; prior history of herpes zoster - Immune globulin and/or blood products given within 5 months prior to or expected within the 6-week post vaccination period - Receipt of any live virus vaccinations within 1 month or receipt of any inactivated vaccinations within 7 days prior to enrollment - Known immune deficiency that is caused by a medical condition - Any use in the 8 weeks prior to vaccination or for 6 weeks after vaccination other medications which may suppress the immune system including methotrexate, corticosteroids at a daily dose greater than 20 mg of prednisone or equivalent, agents used to treat cancer, or medications which alter the level of the immune response used to treat arthritis or other illnesses - Concomitant use of antiviral therapy - All females enrolling must be postmenopausal - A history of alcohol abuse or recreational drug use
If you are interested in this clinical trial please use the contact information above. If you would like to get additional information about this clinical trial please visit ClinicalTrials.gov.
Trials Alerts: If you would like to be notified of new clinical trials as they become available please register for a free account.
Data Source: ClinicalTrials.gov
Date Processed: February 16, 2010
Modifications to
this listing:		 Only selected fields are shown, please use the link above to view all information about this clinical trial.